PharmaCyte Biotech Inc (PMCB): If ViaCyte is subpar as you suggest how...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	42
Posts	4850
Boards Moderated	0
Alias Born	08/06/2012

frosr6

Re: oldmusky post# 72636

Wednesday, 08/02/2017 12:05:00 PM

Wednesday, August 02, 2017 12:05:00 PM

If ViaCyte is subpar as you suggest how are they attracting so much support compared to pmcb which has 0?

Transforming the Lives of Patients with Diabetes
ViaCyte, Inc., a leader in the emerging field of regenerative medicine, is headquartered in San Diego, California. ViaCyte's innovative products are based on the differentiation of stem cells into pancreatic beta cell precursors (PEC-01™), with subcutaneous implantation in a retrievable medical device (Encaptra® cell delivery system). Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence. If successful, ViaCyte’s products will relieve patients of both the acute challenges and risks, as well as the long-term complications, associated with diabetes.
ViaCyte has received substantial financial, scientific, advocacy, and technical support from both the California Institute for Regenerative Medicine (CIRM) and JDRF.
http://viacyte.com

Disclosure: I am involved in and support the SEC whistleblower program, I may be rewarded cash for information that leads to the successful enforcement by the SEC of a federal court or administrative action of 1m+.